Publications
The Case for Manufacturing Drugs in the United States Goes Back 45 Years
June 9, 2025
The Bayh-Dole Act of 1980 requires inventions made wholly or in part with federal funding to be substantially manufactured in the United States. Asher M. Rubin and Cassidy A. Pomeroy-Carter discuss how the 1980 law intended to keep drug manufacturing in the United States.
Contacts
Baltimore
+1 410 559 2881Baltimore
2850 Quarry Lake Drive, Suite 301
Baltimore, MD 21209
Capabilities
Suggested News & Insights
Sidley Represents RoundTable Healthcare Partners in Its Partnership and Investment in ColorescienceFebruary 2, 2026Sidley Represents Simcere in €1 Billion Licensing and Collaboration Agreement With Boehringer IngelheimJanuary 29, 2025Sidley Represents Bonaccord Capital in Increased Minority Investment in Park Square CapitalJanuary 21, 2026Global IR Pitching @ JPM 2026 (Co-hosted by KoreaBIO and Sidley)Tuesday, January 13, 2026Recharge & Recaffeinate with Sidley @ JPMMonday, January 12, 2026 – Tuesday, January 13, 2026Biotech Dealmaking – Regulatory Considerations for the Next Wave of Development-Stage Transactions – Program and Lunch @ JPM 2026Monday, January 12, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory